Top Medical News
Yesterday
Vascular function and glycosylated haemoglobin (HbA1c) both improve with metformin, which also reduces insulin dose, in children with type 1 diabetes (T1D), reports a recent study.
Pearl Toh, 2 days ago
Almost half of the patients with type 2 diabetes (T2D) within the past 6 years reverted to nondiabetic state along with weight reduction and discontinuation of antidiabetic drugs at 12 months, after undertaking dietary and lifestyle intervention in the primary care setting, according to the DiRECT* trial.
2 days ago
Trace levels of lithium in tap water appears to protect against Alzheimer’s disease (AD), obesity and type 2 diabetes, a recent study from Texas has shown.
3 days ago
Aside from infertility, varicoceles may increase the risk of other diseases such as heart disease, diabetes and hyperlipidaemia, a recent study shows.
3 days ago
Regardless of sex, metabolic syndrome (MetS) is a predictor of early carotid atherosclerosis in the general population, according to a recent study.
5 days ago
The cheese matrix controls the impact of dairy fat on postprandial lipaemia in healthy individuals, a recent study has shown.
Jairia Dela Cruz, 6 days ago
Long-term dietary intake of linoleic acid may help prevent the development of type 2 diabetes (T2D), with the linoleic acid metabolite arachidonic acid having no harmful effects, according to a meta-analysis of 20 prospective cohort studies.
Special Reports
05 Apr 2017
At a recent lunch symposium held in conjunction with the 1st Malaysian Advances in Women’s Health Congress 2016, Professor Dr Jamiyah Hassan imparted clinical updates and strategies for the optimization of hormone replacement therapy in menopausal women. Highlights from her presentation are summarized below.
16 Mar 2017
Recently, Dr Peter Lin of the Canadian Heart Research Centre spoke on treatment strategies in the management of dyslipidaemia and T2DM at an AstraZeneca-sponsored continuing medical education event. Highlights of his presentations are summarized below.
20 Jan 2017
At the recent Malaysian Osteoporosis Society 2016 Clinical Practice Guideline (CPG) Meeting held on the 8th of October 2016 at Ibis Styles Ipoh, Dr Hew Fen Lee and Professor Dr Chan Siew Pheng presented clinical guidance on the management of osteoporosis, and discussed whether the benefits of treatment outweigh the risks.
04 Jan 2017
At the Diabetes Asia 2016 Conference organized by the National Diabetes Institute, Professor Jean Claude Mbanya presented the case for why gliclazide modified release (MR; Diamicron® MR, Servier) should be the treatment of choice for early and aggressive control of type 2 diabetes (T2D).
16 Dec 2016
BASALOG – Insulin glargine (rDNA) 100 IU/mL soln for inj (cartridge) – CCM Pharmaceuticals
16 Dec 2016
INVOKANA – Canagliflozin hemihydrate 100 mg and 300 mg FC tab – Johnson & Johnson (Janssen)
Pearl Toh, 07 Dec 2016
Preventing hypertension, diabetes, and obesity, which are the major risk factors for heart failure (HF), by ages 45 and 55 years may lower risks of incident HF and prolong HF-free survival, suggests data from the Cardiovascular Disease Lifetime Risk Pooling Project.
Conference Reports
Roshini Claire Anthony, 29 Nov 2017

Gastric bypass may be an effective method of reducing blood pressure (BP) levels in obese patients with hypertension, according to findings of the GATEWAY* trial presented at the AHA** 2017 Scientific Sessions.

Pearl Toh, 07 Oct 2017
Older age, presence of multiple comorbidities, and longer length of hospital stay, rather than difference in glycaemic control, were associated with an increased risk of 1-year death following admission with severe hypoglycaemia in patients with diabetes, according to a Singapore study.
Elaine Soliven, 02 Oct 2017
The use of continuous glucose monitoring (CGM) is associated with a decreased amount of time spent in hypoglycaemia in patients with type 1 diabetes (T1D), according to a study presented at EASD 2017.
Pearl Toh, 01 Oct 2017
Adding continuous glucose monitoring (CGM) to conventional finger-prick test during pregnancy increases the time spent in the recommended glycaemic target range and improves neonatal health outcomes in patients with type 1 diabetes (T1D) compared with traditional test alone, according to the CONCEPTT* study presented at EASD 2017.
Pearl Toh, 27 Sep 2017
Dapagliflozin improves glycaemic control with sustained weight loss without an increased risk of diabetic ketoacidosis (DKA) in patients with type 1 diabetes (T1D) who are inadequately controlled with insulin, according to the DEPICT-1* study.
Roshini Claire Anthony, 26 Sep 2017

Once-weekly doses of the glucagon-like peptide-1 receptor agonist exenatide plus insulin glargine improved glucose control and weight loss in patients whose type 2 diabetes (T2D) was uncontrolled on basal insulin and metformin, according to findings from the DURATION-7* trial.

Audrey Abella, 26 Sep 2017
The novel, G-protein coupled receptor 119 (GPR119) agonist DS-8500a demonstrated dose-dependent glucose-lowering effects and favourable improvements in lipid parameters that extended up to 12 weeks in Japanese patients with type 2 diabetes mellitus (T2D), according to data presented at EASD 2017.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD